Top Stories

• 

  Trump Can't Revive $475M Libel Suit Against CNN At 11th Circ.

  By Dorothy Atkins

  The Eleventh Circuit upheld a ruling Tuesday tossing President Donald Trump's $475 million lawsuit alleging CNN ...(read more)

• 

  Judge Punts FTC Suit Over Meta's Instagram, WhatsApp Buys

  By Bryan Koenig

  A federal antitrust campaign against major technology platforms suffered a significant blow Tuesday with a D.C. ...(read more)

ADVERTISEMENT


• BREAKING: Trump Taps Norton Rose Atty To Be EEOC General Counsel

  By Anne Cullen

  President Donald Trump has nominated Norton Rose Fulbright's global labor and employment head to serve a four-year term as general counsel of the U.S. Equal Employment Opportunity Commission.

• Sick With Cancer, Jack Abramoff Avoids Jail In Crypto Fraud

  By Bonnie Eslinger

  Disgraced Washington, D.C., lobbyist Jack Abramoff avoided a second stint in prison when a California federal judge sentenced him Tuesday to probation for his role in a cryptocurrency fraud, citing his cooperation with law enforcement and his stage-four cancer.

• Health Co. Execs Convicted In $100M Adderall Sales Scheme

  By Lauren Berg

  A San Francisco federal jury weighing a first-of-its-kind case on Tuesday convicted two digital healthcare company executives of scheming to sell Adderall through deceptive advertising, allegedly bringing in $100 million in illicit profits.

• Ex-FDA Chief Accuses J&J Of Hiding Talc Risks For 50 Years

  By Craig Clough

  A former head of the U.S. Food and Drug Administration spent a contentious day under cross-examination Tuesday in a Los Angeles bellwether trial over claims that Johnson & Johnson's talc products caused two women's ovarian cancer, accusing the company of hiding the products' health risks for over 50 years.

• Delaware Chancery Atty Fee Awards Under Fire In New Report

  By Jeff Montgomery

  Attorney fees in Delaware's Court of Chancery lack "consistent benchmarks" and, for big awards, may fail to reflect "risk or performance," according to a report Tuesday that potentially ratchets up pressure on state lawmakers wary of jeopardizing Delaware's standing as the national hub for corporate law disputes.

• 9th Circ. Halts 1 Of 2 Calif. Corporate Climate Disclosure Laws

  By Rachel Riley

  The Ninth Circuit on Tuesday blocked a new California law requiring large companies to publicly disclose financial risks tied to climate change, barring enforcement as an appeal by the U.S. Chamber of Commerce and other business groups challenging the policy unfolds in federal appellate court.

• Trump Admin May Be Overpromising WOTUS Clarity

  By Juan-Carlos Rodriguez

  The Trump administration says its proposal to shrink the Clean Water Act's reach would reduce regulatory burdens and provide clarity to farmers, homebuilders and other businesses, but it could face court challenges and potential reworking by future administrations.

• Cravath Unveils Associate Bonuses, Multiple Firms Follow

  By Aebra Coe

  Multiple firms swiftly fell in line Tuesday evening just hours after Cravath Swaine & Moore LLP announced associate bonuses in line with those offered last year, continuing a long tradition of BigLaw firms following Cravath's lead on compensation.

• 23andMe Seeks OK On Updated $9M Settlement

  By Emlyn Cameron

  23andMe asked a Missouri bankruptcy judge to approve a deal that will modify a settlement with data breach claimants to encompass more claims and pay $9 million, saying doing so will avoid litigation.

• OCC Clears Banks To Hold Crypto For Blockchain Fees

  By Aislinn Keely

  Banks may hold digital assets required to pay crypto transaction fees and test new crypto platforms, the Office of the Comptroller of the Currency confirmed in a Tuesday interpretive letter.

• CVS Pays $18.2M To Settle False Claims Act Allegations

  By Rae Ann Varona

  CVS Pharmacy Inc. paid the federal government and California a total of $18.2 million to settle allegations it submitted claims for medication reimbursements without verifying that the medications would be for approved diagnoses, the U.S. Department of Justice has announced.

• Fed. Circ. Voids Allergan's $39M Trial Win Over Eyelash Patent

  By Theresa Schliep

  The Federal Circuit on Tuesday reversed a $39 million verdict against Sandoz in Allergan's suit accusing it of infringing an eyelash growth drug patent, finding a Colorado federal jury should have found the patent claim at issue invalid for inadequate written description.